BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 26420975)

  • 21. Autoimmune hepatitis in southern Israel: a 15-year multicenter study.
    Delgado JS; Vodonos A; Malnick S; Kriger O; Wilkof-Segev R; Delgado B; Novack V; Rosenthal A; Menachem Y; Melzer E; Fich A
    J Dig Dis; 2013 Nov; 14(11):611-8. PubMed ID: 23815477
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Liver injury after methylprednisolone pulse therapy in multiple sclerosis is usually due to idiosyncratic drug-induced toxicity rather than autoimmune hepatitis.
    Kimura H; Takeda A; Kikukawa T; Hasegawa I; Mino T; Uchida-Kobayashi S; Ohsawa M; Itoh Y
    Mult Scler Relat Disord; 2020 Jul; 42():102065. PubMed ID: 32259746
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Idiosyncratic drug allergic phenprocoumon-induced hepatitis with subacute liver failure initially misdiagnosed as autoimmune hepatitis.
    Hinrichsen H; Lüttges J; Klöppel G; Fölsch UR; Schmidt WE
    Scand J Gastroenterol; 2001 Jul; 36(7):780-3. PubMed ID: 11444480
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Transplant immunosuppressive agents in non-transplant chronic autoimmune hepatitis: the Canadian association for the study of liver (CASL) experience with mycophenolate mofetil and tacrolimus.
    Chatur N; Ramji A; Bain VG; Ma MM; Marotta PJ; Ghent CN; Lilly LB; Heathcote EJ; Deschenes M; Lee SS; Steinbrecher UP; Yoshida EM
    Liver Int; 2005 Aug; 25(4):723-7. PubMed ID: 15998421
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Immune-mediated Drug-induced Liver Injury Caused by Laninamivir Octanoate Hydrate.
    Kawaguchi T; Arinaga-Hino T; Shimizu M; Tanikawa K; Tokushige T; Hirai S; Nagamatsu H; Tateishi H; Takata A; Ide T; Torimura T
    Intern Med; 2019 Sep; 58(17):2501-2505. PubMed ID: 31118398
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Acute hepatitis in a paediatric patient: immune-mediated drug-induced liver injury or albendazole-induced autoimmune hepatitis?
    Dragutinović N; Barać A; Stevanović G; Đorđić I; Paglietti B; Micić J; Aleksić E; Stojnić J; Martinov Nestorov J
    J Infect Dev Ctries; 2022 Oct; 16(10):1660-1663. PubMed ID: 36332223
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Current therapy for autoimmune hepatitis.
    Montano Loza AJ; Czaja AJ
    Nat Clin Pract Gastroenterol Hepatol; 2007 Apr; 4(4):202-14. PubMed ID: 17404588
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Severe acute autoimmune hepatitis after natalizumab treatment.
    Lisotti A; Azzaroli F; Brillanti S; Mazzella G
    Dig Liver Dis; 2012 Apr; 44(4):356-7. PubMed ID: 22154948
    [No Abstract]   [Full Text] [Related]  

  • 29. [Levofloxacin-induced autoimmune hepatitis. Description of a case].
    García Juárez I; Miquel R; Forns X; Bruguera M
    Gastroenterol Hepatol; 2014 Jan; 37(1):46-8. PubMed ID: 24094621
    [No Abstract]   [Full Text] [Related]  

  • 30. Immunoglobulin G4-associated de novo autoimmune hepatitis after liver transplantation for chronic hepatitis B- and C-related cirrhosis and hepatocellular carcinoma: a case report with literature review.
    Zhao XY; Rakhda MI; Wang TI; Jia JD
    Transplant Proc; 2013 Mar; 45(2):824-7. PubMed ID: 23498828
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Minocycline as a cause of drug-induced autoimmune hepatitis. Report of four cases and comparison with autoimmune hepatitis.
    Goldstein NS; Bayati N; Silverman AL; Gordon SC
    Am J Clin Pathol; 2000 Oct; 114(4):591-8. PubMed ID: 11026106
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A case of difficult-to-treat autoimmune hepatitis successfully managed by TNF-alpha blockade.
    Weiler-Normann C; Wiegard C; Schramm C; Lohse AW
    Am J Gastroenterol; 2009 Nov; 104(11):2877-8. PubMed ID: 19888264
    [No Abstract]   [Full Text] [Related]  

  • 33. Type 2 autoimmune hepatitis overlapping with primary sclerosing cholangitis in a 10-year-old boy.
    Gargouri L; Mnif L; Safi F; Turki F; Majdoub I; Maalej B; Bahri I; Mnif H; Boudawara T; Tahri N; Mahfoudh A
    Arch Pediatr; 2013 Dec; 20(12):1325-8. PubMed ID: 24182664
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Autoimmune hepatitis.
    Krawitt EL
    N Engl J Med; 2006 Jan; 354(1):54-66. PubMed ID: 16394302
    [No Abstract]   [Full Text] [Related]  

  • 35. Amicrobial pustulosis of the folds associated with autoimmune disorders: systemic lupus erythematosus case series and first report on the association with autoimmune hepatitis.
    Méndez-Flores S; Charli-Joseph Y; Saeb-Lima M; Orozco-Topete R; Fernández Sánchez M
    Dermatology; 2013; 226(1):1-4. PubMed ID: 23467024
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Budesonide versus prednisone with azathioprine for the treatment of autoimmune hepatitis in children and adolescents.
    Woynarowski M; Nemeth A; Baruch Y; Koletzko S; Melter M; Rodeck B; Strassburg CP; Pröls M; Woźniak M; Manns MP;
    J Pediatr; 2013 Nov; 163(5):1347-53.e1. PubMed ID: 23810723
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Autoimmune hepatitis and coeliac disease. Simultaneous onset of both diseases.
    Arizaga G; Castiella A; Zubiaurre L; Zapata E
    Gastroenterol Hepatol; 2019; 42(6):391-392. PubMed ID: 29983204
    [No Abstract]   [Full Text] [Related]  

  • 38. [Increased liver values of unknown origin. Also consider autoimmune hepatitis].
    Stiefelhagen P
    MMW Fortschr Med; 2009 Feb; 151(6):17. PubMed ID: 19432244
    [No Abstract]   [Full Text] [Related]  

  • 39. Autoimmune hepatitis associated with Graves' disease.
    Cui B; Abe M; Hidata S; Nakanishi S; Matsuura B; Michitaka K; Yamamoto K; Horiike N; Onji M
    Intern Med; 2003 Apr; 42(4):331-5. PubMed ID: 12729321
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical problem-solving. An intricate interplay.
    Moseley RH; Manoogian B; Shehab T; Saint S
    N Engl J Med; 2012 Oct; 367(14):1342-7. PubMed ID: 23034023
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.